DE602004015970D1 - Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure - Google Patents

Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure

Info

Publication number
DE602004015970D1
DE602004015970D1 DE602004015970T DE602004015970T DE602004015970D1 DE 602004015970 D1 DE602004015970 D1 DE 602004015970D1 DE 602004015970 T DE602004015970 T DE 602004015970T DE 602004015970 T DE602004015970 T DE 602004015970T DE 602004015970 D1 DE602004015970 D1 DE 602004015970D1
Authority
DE
Germany
Prior art keywords
fatty acid
metabolic
inclusion
tissue
blood flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015970T
Other languages
English (en)
Inventor
David R Elmaleh
Alan J Fischman
Timothy M Shoup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE602004015970D1 publication Critical patent/DE602004015970D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DE602004015970T 2003-04-17 2004-04-19 Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure Expired - Lifetime DE602004015970D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46357403P 2003-04-17 2003-04-17
PCT/US2004/012084 WO2004093650A2 (en) 2003-04-17 2004-04-19 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid

Publications (1)

Publication Number Publication Date
DE602004015970D1 true DE602004015970D1 (de) 2008-10-02

Family

ID=33310796

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015970T Expired - Lifetime DE602004015970D1 (de) 2003-04-17 2004-04-19 Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure

Country Status (10)

Country Link
US (9) US7494642B2 (de)
EP (1) EP1622602B1 (de)
JP (1) JP4633052B2 (de)
AT (1) ATE405258T1 (de)
AU (1) AU2004232297B2 (de)
CA (1) CA2522737C (de)
DE (1) DE602004015970D1 (de)
HK (1) HK1083414A1 (de)
MX (1) MXPA05011189A (de)
WO (1) WO2004093650A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636881T2 (de) * 1995-12-01 2007-09-20 Molecular Insight Pharmaceuticals, Inc., Cambridge Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
US8489176B1 (en) 2000-08-21 2013-07-16 Spectrum Dynamics Llc Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US8565860B2 (en) 2000-08-21 2013-10-22 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system
US8909325B2 (en) 2000-08-21 2014-12-09 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
AU2004232297B2 (en) * 2003-04-17 2010-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
WO2008010227A2 (en) 2006-07-19 2008-01-24 Spectrum Dynamics Llc Imaging protocols
WO2006051531A2 (en) 2004-11-09 2006-05-18 Spectrum Dynamics Llc Radioimaging
US7968851B2 (en) 2004-01-13 2011-06-28 Spectrum Dynamics Llc Dynamic spect camera
CN1981210A (zh) 2004-01-13 2007-06-13 光谱动力学有限责任公司 多维图像重构
US8571881B2 (en) 2004-11-09 2013-10-29 Spectrum Dynamics, Llc Radiopharmaceutical dispensing, administration, and imaging
US8586932B2 (en) 2004-11-09 2013-11-19 Spectrum Dynamics Llc System and method for radioactive emission measurement
US9470801B2 (en) 2004-01-13 2016-10-18 Spectrum Dynamics Llc Gating with anatomically varying durations
EP1778957A4 (de) 2004-06-01 2015-12-23 Biosensors Int Group Ltd Optimierung der messung radioaktiver strahlung an besonderen körperstrukturen
US9943274B2 (en) 2004-11-09 2018-04-17 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
US9316743B2 (en) 2004-11-09 2016-04-19 Biosensors International Group, Ltd. System and method for radioactive emission measurement
US8615405B2 (en) 2004-11-09 2013-12-24 Biosensors International Group, Ltd. Imaging system customization using data from radiopharmaceutical-associated data carrier
US8423125B2 (en) 2004-11-09 2013-04-16 Spectrum Dynamics Llc Radioimaging
WO2008059489A2 (en) 2006-11-13 2008-05-22 Spectrum Dynamics Llc Radioimaging applications of and novel formulations of teboroxime
EP1909853B1 (de) 2005-07-19 2015-03-18 Biosensors International Group, Ltd. Bildgebungsprotokolle
US8837793B2 (en) 2005-07-19 2014-09-16 Biosensors International Group, Ltd. Reconstruction stabilizer and active vision
GB0525949D0 (en) 2005-12-21 2006-02-01 Hammersmith Imanet Ltd Pet radiotracers
US20090177098A1 (en) * 2006-01-16 2009-07-09 Kousuke Yakubo Examination System and Examination Method
US8894974B2 (en) 2006-05-11 2014-11-25 Spectrum Dynamics Llc Radiopharmaceuticals for diagnosis and therapy
WO2008075362A2 (en) 2006-12-20 2008-06-26 Spectrum Dynamics Llc A method, a system, and an apparatus for using and processing multidimensional data
US8521253B2 (en) 2007-10-29 2013-08-27 Spectrum Dynamics Llc Prostate imaging
CA2760334A1 (en) * 2009-05-04 2010-11-11 Washington University Pet radiotracers for imaging fatty acid metabolism and storage
US20120237937A1 (en) * 2009-06-12 2012-09-20 University Of Louisville Research Foundation, Inc. Methods to detect cancer in animals
US8338788B2 (en) 2009-07-29 2012-12-25 Spectrum Dynamics Llc Method and system of optimized volumetric imaging
US20110110570A1 (en) * 2009-11-10 2011-05-12 Avi Bar-Shalev Apparatus and methods for generating a planar image
DE102010010666A1 (de) * 2010-03-01 2011-09-01 Sven Reske Diagnose und Therapie von Krebserkrankungen mittels Fettsäuren
EP3041414B1 (de) * 2013-09-06 2018-10-10 Koninklijke Philips N.V. Verarbeitungsvorrichtung zur verarbeitung von herzdaten
WO2018089491A1 (en) * 2016-11-08 2018-05-17 The Regents Of The University Of California Methods for multi-dose synthesis of [f-18]fddnp for clinical settings
CN108727229B (zh) * 2017-04-17 2021-07-02 北京先通国际医药科技股份有限公司 一种修饰脂肪酸型pet试剂前体的新工艺路线
CN112638868B (zh) * 2018-07-20 2023-06-20 安斯泰来制药株式会社 由正电子放射性核素标记的脂肪酸衍生物
CN116351339A (zh) * 2022-06-07 2023-06-30 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114732918B (zh) * 2022-06-10 2022-09-13 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114736112A (zh) * 2022-06-14 2022-07-12 北京先通国际医药科技股份有限公司 一种心肌代谢pet显像剂的制备方法及用途
CN114773179B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 一种化合物ⅰ液体组合物的制备方法、及其在心肌代谢pet显像上的用途
CN114796534B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 包含化合物ⅰ的液体组合物、制备方法及用途
CN115181013B (zh) * 2022-07-22 2023-08-08 北京先通国际医药科技股份有限公司 修饰脂肪酸型pet试剂前体关键中间体的制备方法及其用途
CN116199658A (zh) * 2022-07-22 2023-06-02 北京先通国际医药科技股份有限公司 一种修饰长链脂肪酸型pet试剂前体的合成方法及其用途
CN116217356A (zh) * 2022-09-06 2023-06-06 北京先通国际医药科技股份有限公司 Pet前体关键中间体的异构体的合成方法及其用途
CN115970012A (zh) * 2023-03-16 2023-04-18 北京先通国际医药科技股份有限公司 正电子心肌脂肪酸代谢显像剂与正电子18f-fdg心肌葡萄糖显像剂用于pet联合显像的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119640A (en) * 1975-07-10 1978-10-10 Union Carbide Corporation Polymerizable epoxide-modified compositions
DE2828623C2 (de) * 1978-06-29 1983-11-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung
US4202902A (en) * 1979-03-05 1980-05-13 Shell Oil Company Lipogenesis control by cyclopropane-carboxylic acids, esters and amides
US4524059A (en) * 1983-01-28 1985-06-18 The General Hospital Corporation Fatty acid analogs
US4933365A (en) * 1989-01-25 1990-06-12 American Home Products Corporation Phospholipase A2 inhibitors
DE4012405C1 (en) * 1990-04-19 1991-08-14 Forschungszentrum Juelich Gmbh, 5170 Juelich, De Radioisotope labelled oxiranyl carboxylic acid derivs. prodn. - by nucleophilic replacement of corresp. bromo or iodo substits. with radioactive alkali halide(s) in polar medium
DE69636881T2 (de) 1995-12-01 2007-09-20 Molecular Insight Pharmaceuticals, Inc., Cambridge Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
IT1295658B1 (it) * 1997-09-29 1999-05-24 Menarini Ricerche Spa Composizioni farmaceutiche contenenti acido ricinoleico e loro uso per la terapia antifiammatoria ed analgesica
EP1173226B1 (de) * 1999-04-14 2006-08-23 Molecular Insight Pharmaceuticals, Inc. Fettsaure analoge zur diagnose von kranzarterie erkrankungen
WO2004092184A1 (de) 2003-04-12 2004-10-28 Forschungszentrum Rossendorf E.V. Technetiummarkierte fettsäuren und deren verwendung für die myokarddiagnostik sowie verfahren zur herstellung der technetiummarkierten fettsäuren
AU2004232297B2 (en) * 2003-04-17 2010-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
JP5520286B2 (ja) * 2008-04-04 2014-06-11 アドバンスト・マイクロ・ディバイシズ・インコーポレイテッド アンチエイリアシングのためのフィルタ処理方法及び装置

Also Published As

Publication number Publication date
JP2006524250A (ja) 2006-10-26
US20040253177A1 (en) 2004-12-16
CA2522737C (en) 2017-06-06
WO2004093650A2 (en) 2004-11-04
US20130052129A1 (en) 2013-02-28
EP1622602B1 (de) 2008-08-20
US8871179B2 (en) 2014-10-28
US20080095702A1 (en) 2008-04-24
US20080213173A1 (en) 2008-09-04
US7790142B2 (en) 2010-09-07
US20080214851A1 (en) 2008-09-04
JP4633052B2 (ja) 2011-02-16
CA2522737A1 (en) 2004-11-04
MXPA05011189A (es) 2006-05-25
EP1622602A2 (de) 2006-02-08
US20080206135A1 (en) 2008-08-28
US20090156848A1 (en) 2009-06-18
AU2004232297A1 (en) 2004-11-04
US20080214853A1 (en) 2008-09-04
US7494642B2 (en) 2009-02-24
AU2004232297B2 (en) 2010-11-04
US8309053B2 (en) 2012-11-13
ATE405258T1 (de) 2008-09-15
EP1622602A4 (de) 2006-06-21
US8268291B2 (en) 2012-09-18
HK1083414A1 (en) 2006-06-30
WO2004093650A3 (en) 2005-04-14
US20080213178A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
DE602004015970D1 (de) Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure
DE60324180D1 (de) Behandlung der huntington's krankheit mit epa
EA200802213A1 (ru) Способы лечения заболеваний крови
AR002240A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
PE20061397A1 (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos productos y metodos de preparacion
DE602005020269D1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
BRPI0510623A (pt) compostos de derivados de prolina e morfolina
EA200401365A1 (ru) Способы лечения илеуса
DK1812076T3 (da) Blodpladeafledte vækstfaktorsammensætninger og fremgangsmåder til anvendelse heraf
ATE478062T1 (de) Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
DE602005012233D1 (de) Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren
DE60335552D1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
DE69915223D1 (de) Neue heterocyclische analoge von diphenylethylenverbindungen
BRPI0410979A (pt) composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
BRPI0408388A (pt) compostos de benzopirano úteis no tratamento de patologias inflamatórias
ATE400272T1 (de) Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
SE9904421D0 (sv) New compounds
EA200200232A1 (ru) Интерлейкин-5 ингибирующие производные 6-азаурацила
WO2006113907A3 (en) Escherichia coli o157:h7 proteins and uses thereof
DK1360178T3 (da) Hidtil ukendte heterocykliske analoger af diphenylethylenforbindelser
WO2006068306A3 (en) COMPOSITION FOR STERILIZATION COMPRISING ω-ALKOXYPEROXYCARBOXYLIC ACID
BRPI0415434A (pt) compostos e métodos para tratar e prevenir arritmias cardìacas induzidas por exercìcios
SE0101978D0 (sv) New compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition